Allylammonium chloride

Suppliers

Names

[ CAS No. ]:
10017-11-5

[ Name ]:
Allylammonium chloride

[Synonym ]:
Prop-2-en-1-amine hydrochloride (1:1)
2-Propen-1-amine hydrochloride
2-Propen-1-amine, hydrochloride (1:1)
3-Aminopropene hydrochloride
MFCD00054329
Allylammonium chloride
2-propen-1-amine, hydrochloride
2-Propen-1-amine hydrochloride (1:1)
Allylamine Hydrochloride
Allylamine, hydrochloride

Chemical & Physical Properties

[ Boiling Point ]:
54.3ºC at 760mmHg

[ Melting Point ]:
106 °C

[ Molecular Formula ]:
C3H8ClN

[ Molecular Weight ]:
93.555

[ Exact Mass ]:
93.034531

[ PSA ]:
26.02000

[ LogP ]:
1.63340

[ Vapour Pressure ]:
247mmHg at 25°C

[ Index of Refraction ]:
1.414

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
BA6950000
CHEMICAL NAME :
Allylamine, hydrochloride
CAS REGISTRY NUMBER :
10017-11-5
LAST UPDATED :
199612
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C3-H7-N.Cl-H

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JJATDK JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W. Sussex PO19 1UD, UK) V.1- 1981- Volume(issue)/page/year: 9,235,1989 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1400 mg/kg/20D-I
TOXIC EFFECTS :
Vascular - structural changes in vessels Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death
REFERENCE :
JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- Volume(issue)/page/year: 29,357,1990
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
42 gm/kg/40W-C
TOXIC EFFECTS :
Cardiac - cardiomegaly Vascular - structural changes in vessels
REFERENCE :
AJPAA4 American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- Volume(issue)/page/year: 66,225,1972
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - quail
DOSE/DURATION :
140 mg/kg/20D-I
TOXIC EFFECTS :
Vascular - structural changes in vessels Vascular - other changes Related to Chronic Data - death
REFERENCE :
JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- Volume(issue)/page/year: 29,357,1990

Safety Information

[ Symbol ]:

GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301

[ Precautionary Statements ]:
P301 + P310

[ Hazard Codes ]:
T

[ Risk Phrases ]:
23/24/25-51/53

[ Safety Phrases ]:
S26-S36/37/39

[ RIDADR ]:
2811

[ RTECS ]:
BA6950000

[ HS Code ]:
2921199090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 1-Bromodecane
  • 1-Bromo-6-(trimethylammonium)hexyl Bromide
  • tert-butyl allyl(diethoxyphosphoryl)carbamate
  • n-allyl-n n-bis(trimethylsilyl)amine
  • N-tritylprop-2-en-1-amine

DownStream

  • 3-aminopropanethiol
  • N-(2-phenylethyl)prop-2-en-1-amine
  • 2-Phenylethanamine
  • 4-nitro-N-prop-2-enyl-2,1,3-benzoxadiazol-7-amine
  • 4-(hydroxymethyl)-3-prop-2-enyl-1H-imidazole-2-thione
  • AKOS BBS-00007306
  • 2-(prop-2-enylamino)acetonitrile
  • 1,1-diphenyl-N-prop-2-enylmethanimine

Customs

[ HS Code ]: 2921199090

[ Summary ]:
2921199090 other acyclic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

Highly magneto-responsive multilayer microcapsules for controlled release of insulin.

Int. J. Pharm. 475(1-2) , 17-24, (2014)

In this study, magneto-responsive polyelectrolyte multilayer microcapsules were successfully prepared by the formation of shell with biocompatible iron oxide nanoparticles (Fe₃O₄ NPs) and polyallylami...

Biodegradable nano-films for capture and non-invasive release of circulating tumor cells.

Biomaterials 65 , 93-102, (2015)

Selective isolation and purification of circulating tumor cells (CTCs) from whole blood is an important capability for both clinical medicine and biological research. Current techniques to perform thi...

Polyelectrolyte multilayer-assisted fabrication of non-periodic silicon nanocolumn substrates for cellular interface applications.

Nanoscale 7 , 14627-35, (2015)

Recent advances in nanostructure-based biotechnology have resulted in a growing demand for vertical nanostructure substrates with elaborate control over the nanoscale geometry and a high-throughput pr...


More Articles

Related Compounds

  • Allylammonium chloride
  • Strontium chloride-Sr82
  • Benzoyl chloride, 4-(1-methylpropyl)- (9CI)
  • Benzenebutanoyl chloride, 3-chloro-
  • cyclopentadienylmagnesium chloride
  • Cyclohexanecarbonyl chloride, 2-(acetyloxy)-, trans- (9CI)
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • (2-Cyclohexyl-4,6-dimethylpiperidin-3-yl)methanamine
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide